On April 21, 2026, a judge is expected to sentence Purdue Pharma, the company behind OxyContin, to forfeit $225 million to the Justice Department.
This forfeiture is a significant step that may allow Purdue Pharma to finalize its settlement, which has been in the works.
The ruling is part of ongoing legal proceedings related to the company's role in the opioid crisis.